Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib + Letrozole in HR+/HER2- Locally Advanced Breast Cancer
NCT04047758Phase 3Unknown
- Sponsor
- Shengjing Hospital of China Medical University
- Start
- Sep 2019
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of palbociclib in breast cancer, sponsored by Shengjing Hospital of China Medical University. Status: unknown.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04047758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04047758.